[INTERVIEW] We Have Mobilized $2m to Support COVID-19 Relief Efforts in Africa -MuchilwaHead of Sub-Sahara Africa at Novartis, Racey Muchilwa in this interview, highlights issues underpinning COVID-19 pandemic response in Africa, the role Novartis is currently playing, particularly in supporting relief efforts across the continent, as well as other sundry topical issues. As Head of Novartis Sub Saharan Africa, what is your evaluation of Covid-19 pandemic since the virus hit that region? It’s for this reason that we have mobilized $2 million grant funding to 18 Non-Governmental Organizations (NGOs) in Africa to support their pandemic relief efforts. We have also provided hydroxychloroquine upon request and most recently announced the Novartis Pandemic Response Portfolio for countries with inherently fragile healthcare systems. Your company is big on R&D, how much of it has been done and ongoing on Covid-19 pandemic in relation to Sub Saharan Africa?